Buy Bio-Path Holdings Stock | BPTH Stock Price & Latest News | Public
BPTH

Bio-Path Holdings

$0.00 (0.00%)Today
    Small Market Cap

    About BPTH

    Bio-Path Holdings, Inc. is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline include Prexigebersen, BP1002, and BP1003. The company was founded by Peter Nielsen...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.3
    -0.6
    -0.9
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.78

    Actual EPS
    Q4 2020

    Stats

    Market Cap$15,12M
    Volume970
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$8.65
    1 Year Low$2.92
    Open$3.39
    High$3.39
    Low$3.33

    Buy any stock with any amount of money.

    Download the App
    Download the app